Eliprodil

DB12869InvestigationalSmall molecule

Eliprodil has been used in trials studying the treatment of Parkinson Disease and Movement Disorders.

Chemical structure of Eliprodil
Formula / weight
C20H23ClFNO · 347.86 g/mol (avg)

Resolves to

Compound
UNIIYW62A6TW29CAS119431-25-3ChEMBLCHEMBL28564ChEBI91784PubChem60703
Structure
InChIKeyGGUSQTSTQSHJAH-UHFFFAOYSA-NSMILESOC(CN1CCC(CC2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
Targets
Q13224GRIN2BQ05586GRIN1

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Eliprodil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In